Minimally Invasive Thoracic Surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiologists ASA Grade I ~ III; 2. Elective patients who plan to undergo minimally invasive thoracic surgery; 3, age 18-65 years old; 4. The subjects voluntarily joined the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Liver and kidney insufficiency; 2. Allergic to the drug to be used;3. History of chronic pain; 4. History of opioid dependence or opioid use >1 month; 5, dementia, language disorders or neuropsychiatric disorders can not cooperate with patients; 6. Patients with contraindications to regional anesthesia; 7. Patients who were accidentally converted to thoracotomy during minimally invasive thoracic surgery or were admitted to ICU for continued mechanical ventilation after surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dosage of sufentanil 24h after operation in two groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS score;First compression time for controlled analgesia;Quality of recovery 24 hours after surgery was assessed by QoR-15 questionnaire;Nerve block operation time T0, number of puncture;Drainage tube removal time; | — |
Countries
CHINA
Contacts
Shenzhen Second People's Hospital